Related Experiment Video

Updated: May 17, 2026

Model of Ischemia and Reperfusion Injury in Rabbits
06:11

Model of Ischemia and Reperfusion Injury in Rabbits

Published on: November 3, 2023

Reperfusion therapies reduce ischemic mitral regurgitation following inferoposterior ST-segment elevation myocardial

Kian-Keong Poh1, Glenn K Lee, Li-Ching Lee

  • 1Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. kian_keong_poh@nuhs.edu.sg

Coronary Artery Disease
|October 30, 2012
PubMed
Abstract

Insights

Reperfusion therapy, including primary percutaneous coronary intervention (PCI) and thrombolysis, significantly reduces ischemic mitral regurgitation (IMR) after ST-segment elevation myocardial infarction (STEMI). This improves outcomes for patients with inferoposterior STEMI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Imaging

Background:

  • Ischemic mitral regurgitation (IMR) following ST-segment elevation myocardial infarction (STEMI) is linked to worse patient prognosis.
  • The impact of reperfusion strategies on mitral valve competence in inferoposterior STEMI remains incompletely understood.

Purpose of the Study:

  • To investigate the effect of reperfusion therapy on the incidence of IMR in patients experiencing inferoposterior STEMI.
  • To compare outcomes between reperfusion therapy and medical management for inferoposterior STEMI regarding IMR.

Main Methods:

  • A cohort of 423 patients with first inferoposterior STEMI was analyzed.
  • Patients were categorized based on treatment: primary percutaneous coronary intervention (PCI), thrombolysis, rescue PCI, or medical therapy.
  • Echocardiography was performed to assess IMR, with a mean interval of 14 ± 27 days post-STEMI.

Main Results:

  • Reperfusion therapy (primary PCI, thrombolysis, rescue PCI) was associated with a significantly lower incidence of moderate to severe IMR (2.5%) compared to medical therapy (11.1%, P=0.001).
  • No significant difference in IMR incidence was observed between primary PCI and thrombolysis groups.
  • Patients with IMR exhibited worse left ventricular ejection fraction and larger infarct size (mean CK-MB).

Conclusions:

  • Both thrombolytic therapy and primary PCI are effective in reducing the incidence of IMR after inferoposterior STEMI.
  • IMR is associated with adverse left ventricular remodeling and potentially poorer long-term outcomes, including heart failure readmission.

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...